Literature DB >> 1941611

Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates.

C A Broomfield1, D M Maxwell, R P Solana, C A Castro, A V Finger, D E Lenz.   

Abstract

Butyrylcholinesterase (BuChE) was examined as an in vivo exogenous scavenger for highly toxic organophosphorus (OP) poisons. Protection studies with equine BuChE were carried out in rhesus monkeys trained to perform a Serial Probe Recognition task. The pharmacokinetics of equine BuChE administered i.v. in rhesus monkeys revealed an elimination T1/2 of approximately 620 hr. Animals given 503 nmol of BuChE i.v. and then challenged with 220 to 260 nmol of soman (two LD50; a lethal dose in untreated animals) all survived with no clinical signs of OP poisoning. Serial Probe Recognition performance was depressed after enzyme administration and at 1 hr postsoman. However, all monkeys performed the task at base-line levels at 8 hr after soman and throughout the remainder of the experimental period. Two different monkeys each were given two doses of sarin, 183 nmol/dose (one LD50) after 460 nmol of BuChE. No signs were observed. A third group of monkeys given 253 or 340 nmol (three and four LD50, respectively) of soman after 460 nmol of BuChE required 1 mg/kg of atropine i.v. 10 min postsoman, but recovered completely within 24 hr. Our results indicate that BuChE has the required properties to function as a biological scavenger to protect against the pharmacological and behavioral toxicity of OP poisons.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1941611

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  22 in total

1.  Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation.

Authors:  C Kronman; B Velan; D Marcus; A Ordentlich; S Reuveny; A Shafferman
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

2.  Toxicokinetics of soman stereoisomers after subcutaneous administration to atropinized guinea pigs.

Authors:  A H Due; H C Trap; J P Langenberg; H P Benschop
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

3.  LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY.

Authors:  Oksana Lockridge; Lawrence M Schopfer; Gail Winger; James H Woods
Journal:  J Med Chem Biol Radiol Def       Date:  2005-07-01

4.  Development of versatile and potent monoquaternary reactivators of acetylcholinesterase.

Authors:  Lukas Gorecki; Vendula Hepnarova; Jana Zdarova Karasova; Martina Hrabinova; Charlotte Courageux; José Dias; Tomas Kucera; Tereza Kobrlova; Lubica Muckova; Lukas Prchal; David Malinak; Daniel Jun; Kamil Musilek; Franz Worek; Florian Nachon; Ondrej Soukup; Jan Korabecny
Journal:  Arch Toxicol       Date:  2021-01-31       Impact factor: 5.153

5.  Why does the G117H mutation considerably improve the activity of human butyrylcholinesterase against sarin? Insights from quantum mechanical/molecular mechanical free energy calculations.

Authors:  Yuan Yao; Junjun Liu; Chang-Guo Zhan
Journal:  Biochemistry       Date:  2012-10-23       Impact factor: 3.162

6.  Intrathecal delivery of fluorescent labeled butyrylcholinesterase to the brains of butyrylcholinesterase knock-out mice: visualization and quantification of enzyme distribution in the brain.

Authors:  Noel D Johnson; Ellen G Duysen; Oksana Lockridge
Journal:  Neurotoxicology       Date:  2009-03-20       Impact factor: 4.294

7.  The combination of huperzine A and imidazenil is an effective strategy to prevent diisopropyl fluorophosphate toxicity in mice.

Authors:  Fabio Pibiri; Alan P Kozikowski; Graziano Pinna; James Auta; Bashkim Kadriu; Erminio Costa; Alessandro Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-10       Impact factor: 11.205

8.  The proline-rich tetramerization peptides in equine serum butyrylcholinesterase.

Authors:  Kevser Biberoglu; Lawrence M Schopfer; Ozden Tacal; Oksana Lockridge
Journal:  FEBS J       Date:  2012-09-07       Impact factor: 5.542

9.  Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels.

Authors:  T Chitlaru; C Kronman; M Zeevi; M Kam; A Harel; A Ordentlich; B Velan; A Shafferman
Journal:  Biochem J       Date:  1998-12-15       Impact factor: 3.857

10.  Reactivation of sarin-inhibited pig brain acetylcholinesterase using oxime antidotes.

Authors:  Kamil Kuca; Daniel Jun
Journal:  J Med Toxicol       Date:  2006-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.